6/19 Theory
et al., In Vivo, 34:5, 3023-3026, doi:10.21873/invivo.12134 (Theory)
Ivermectin Docks to the SARS-CoV-2 Spike Receptor-binding Domain Attached to ACE2
Ivermectin Docks to the SARS-CoV-2 Spike Receptor-binding Domain Attached to ACE2
In silico analysis showing ivermectin docking which may interfere with the attachment of the spike to the human cell membrane.
Lehrer et al., 6/19/2020, preprint, 2 authors.
